An open-label, in-use study assessing the warming sensation accompanying IFF Flavour 316282 and the acceptability and local tolerability of a syrup containing paracetamol and pseudoephedrine for the short-term treatment of symptoms of an upper respiratory tract infection.

Journal: SAGE open medicine
Published Date:

Abstract

OBJECTIVE: The primary objective was to assess the warming sensation caused by IFF Flavour 316282 in a syrup used for short-term treatment by patients suffering from nasal congestion and mild to moderate body pain, headache, fever or sore throat associated with an upper respiratory tract infection.

Authors

  • Rowland Furcha
    Novartis Consumer Health S.A., Nyon, Switzerland.
  • JoĆ«lle Monnet
    Novartis Consumer Health S.A., Nyon, Switzerland.

Keywords

No keywords available for this article.